ClinicalTrials.Veeva

Menu

Phenotypic Expressions in a French Pseudoxanthoma-Elasticum Cohort

U

University Hospital, Angers

Status

Unknown

Conditions

Pseudoxanthoma Elasticum

Study type

Observational

Funder types

Other

Identifiers

NCT01446380
AC 2008 871

Details and patient eligibility

About

The cohort is intended to study the phenotypic expressions of the pseudoxanthoma elasticum (PXE) disease in various tissues (eye, skin, arteries, etc).

Full description

This national french cohort is intended to improve our knowledge on the PXE disease. The study of phenotypic expression of the diseases is focused on cutaneous, opthalmologic and vascular tissues. All investigations are included in a yearly follow-up for these patients and collected in a database.

Plasma are also collected for all patients and stored in our clinical research biological center in Angers, including genetic (DNA) material extracted from diagnostic skin biopsy. French Ministry of Teaching and Research Authorisation number for the PXE collection is AC 2008 871. Declarative number is DC 2008 870.

Enrollment

350 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with PXE disease
  • Informed consent obtained
  • Patient affiliated to Health care system (french social security)

Exclusion criteria

  • No informed consent
  • No affiliation to a Health care system

Trial design

350 participants in 1 patient group

Pseudoxanthoma elasticum

Trial contacts and locations

1

Loading...

Central trial contact

Ludovic MARTIN, MD PhD; Georges LEFTHERIOTIS, MD-PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems